SCHEMBL30257775

CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O

nearest known ligand 0.56

Predicted protein targets (top 15)

	gene	UniProt	supporting neighbours	confidence
▸	CXCR4	P61073	7/20	0.56

▸	NPY1R	P25929	1/20	0.50

▸	NPY2R	P49146	1/20	0.50

▸	NPY4R	P50391	1/20	0.50

▸	NPY5R	Q15761	1/20	0.50

▸	CAPN1	P07384	2/20	0.47

▸	CTSB	P07858	2/20	0.47

▸	MAPK8	P45983	1/20	0.47

▸	MAPK9	P45984	1/20	0.47

▸	MAPK10	P53779	1/20	0.47

▸	CCKBR	P32239	2/20	0.47

▸	GLP1R	P43220	2/20	0.47

▸	CALCRL	Q16602	1/20	0.47

▸	KISS1R	Q969F8	3/20	0.46

▸	DPP3	Q9NY33	2/20	0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30199257	0.90	CXCR4 (0.57)	CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL30257218	0.90	CXCR4 (0.61)	CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL30199081	0.89	CAPN1 (0.54)	CXCR4CAPN1CTSBCALCRLKISS1R
SCHEMBL30199355	0.85	CXCR4 (0.61)	CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL7399755	0.84	MAGI3 (0.55)	CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL7402113	0.84	MAGI3 (0.56)	CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL30256961	0.83	CXCR4 (0.59)	CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL10587346	0.82	CXCR4 (0.65)	CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL29706251	0.81	CXCR4 (0.58)	CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL30974317	0.81	DPP3 (0.58)	CXCR4CAPN1CTSBCCKBRCALCRL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20230116689-A1	METHODS AND BIOLOGICAL SYSTEMS FOR DISCOVERING AND OPTIMIZING LASSO PEPTIDES	LASSOGEN, INC.	2023-04-13	—	—	US	disclosed